- Conditions
- Essential Tremor, Neuromodulation
- Interventions
- Focused Ultrasound Neuromodulation - Sham Control, Focused ultrasound neuromodulation
- Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
Clinical trials at UCSF
Sites in San Francisco, CA
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Live official records
- Conditions
- Chronic Pelvic Pain Syndrome (CPPS), Chronic Pelvic Pain Syndrome, Chronic Pelvic Pain
- Interventions
- Pelvic floor yoga, Physical conditioning
- Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- San Francisco, California
TReating Incontinence for Underlying Mental and Physical Health
- Conditions
- Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder, Incontinence, Urge, Incontinence, Urinary, Incontinence
- Interventions
- Tolterodine Tartrate ER, Mirabegron, Placebo
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 270 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2027
- U.S. locations
- 2
- States / cities
- Palo Alto, California • San Francisco, California
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
- Conditions
- Dental Caries
- Interventions
- PILP Cement, PILP Conditioner
- Device
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- San Francisco, California
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
- Conditions
- Post-operative Pain Management
- Interventions
- Atricure CryoSPHERE MAX Probe
- Device
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 148 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 3
- States / cities
- Los Angeles, California • San Francisco, California • Waco, Texas
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- Conditions
- Thoracoabdominal Aortic Aneurysm, Paravisceral Abdominal Aortic Aneurysm
- Interventions
- Endovascular Branched Stent-Graft
- Device
- Lead sponsor
- Warren J. Gasper, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2027
- U.S. locations
- 2
- States / cities
- San Francisco, California
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
- Conditions
- Acute Kidney Injury
- Interventions
- Allogeneic HB-adMSCs, Normal Saline
- Drug
- Lead sponsor
- Hope Biosciences LLC
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • San Francisco, California • Houston, Texas
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
- Conditions
- Multiple Myeloma
- Interventions
- Rimiducid may be administered as indicated
- Drug
- Lead sponsor
- Poseida Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2032
- U.S. locations
- 13
- States / cities
- Davis, California • San Diego, California • San Francisco, California + 8 more
Study of Psilocybin for Anorexia in Young Adults
- Conditions
- Anorexia Nervosa
- Interventions
- Psilocybin, Preparation and Integration Sessions
- Drug · Behavioral
- Lead sponsor
- Marissa Raymond-Flesch, MD, MPH
- Other
- Eligibility
- 18 Years to 25 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 2
- States / cities
- San Francisco, California
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
- Conditions
- Heart Failure
- Interventions
- Daily Voice Recording
- Other
- Lead sponsor
- Noah Labs
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- San Francisco, California
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
- Conditions
- Cancer
- Interventions
- Antibody-Drug Conjugate
- Drug
- Lead sponsor
- MBrace Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 17
- States / cities
- San Francisco, California • Aurora, Colorado • Atlanta, Georgia + 13 more
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
- Conditions
- AKI, AKI - Acute Kidney Injury, Dialysis Patients
- Interventions
- Transmission of additional AKI-D recovery information, No additional AKI-D recovery information
- Behavioral · Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- San Francisco, California
About this UCSF institution page
- What this page lists
- ClinicalTrials.gov records that list UCSF in San Francisco, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
- Site status
- A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages, trials led by University of California, San Francisco at any site, browse by condition, or browse by U.S. city.